A Form 4 filed on September 10, 2026 discloses that Kim Kelderman, a director of CONMED Corp (NASDAQ:CNMD), received a grant of 500 restricted stock units on September 8, 2026 under the company's 2025 Long-Term Incentive Plan.

Key Highlights

  • Reporting Person: Kim Kelderman, listed as a Director of CONMED Corp.
  • Transaction Date: September 8, 2026, with the form filed September 10, 2026.
  • Securities Granted: 500 restricted stock units (RSUs) acquired at a price of $0, transaction code M.
  • Resulting Ownership: 500 shares of common stock beneficially owned directly following the transaction.
  • Vesting Schedule: According to the filing, the RSUs generally vest 100% after a one-year period.
  • Plan: The grant is subject to the terms and conditions of CONMED Corporation's 2025 Long-Term Incentive Plan.

CONMED Director Receives 500 RSUs Under 2025 Long-Term Incentive Plan

According to the filing, Kim Kelderman, identified as a Director of CONMED Corp, received 500 restricted stock units on September 8, 2026. The transaction is coded "M," reflecting the conversion of a derivative security. Both the acquisition of the RSUs and their underlying common stock are reported at a price of $0.

The filing states that each RSU "represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation" and that the RSUs "will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period." Following the reported transaction, Kelderman directly holds 500 shares of CONMED common stock, with zero RSUs remaining, as reported in Table II of the filing.

The form was signed by Thomas Fistek for Kim Kelderman by Power of Attorney and dated September 10, 2026. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934, and was filed by one reporting person.

What Was Disclosed

The Form 4 discloses a grant of 500 RSUs to CONMED Director Kim Kelderman on September 8, 2026, under the 2025 Long-Term Incentive Plan, converting to 500 shares of common stock with a one-year vesting period.